akrx

osinod

Banned
interessante
 

Allegati

  • akrx.jpg
    akrx.jpg
    121,1 KB · Visite: 207
ultimo +10%


Key StatisticsGet Key Statistics for:

Data provided by Capital IQ, except where noted.
VALUATION MEASURES


Market Cap (intraday)
5:83.82M

Enterprise Value (4-May-09)[SIZE=-1]3[/SIZE]:80.87M
Trailing P/E (ttm, intraday):N/A
Forward P/E (fye 31-Dec-10) [SIZE=-1]1[/SIZE]:5.47
PEG Ratio (5 yr expected):N/A
Price/Sales (ttm):0.82
Price/Book (mrq):1.25
Enterprise Value/Revenue (ttm)[SIZE=-1]3[/SIZE]:0.86
Enterprise Value/EBITDA (ttm)[SIZE=-1]3[/SIZE]:-30.728
FINANCIAL HIGHLIGHTS Fiscal Year
Fiscal Year Ends:31-Dec
Most Recent Quarter (mrq):31-Dec-08
Profitability
Profit Margin (ttm):-8.48%
Operating Margin (ttm):-7.67%
Management Effectiveness
Return on Assets (ttm):-5.30%
Return on Equity (ttm):-12.59%
Income Statement
Revenue (ttm):93.60M
Revenue Per Share (ttm):1.049
Qtrly Revenue Growth (yoy):89.90%
Gross Profit (ttm):26.59M
EBITDA (ttm):-2.63M
Net Income Avl to Common (ttm):-7.94M
Diluted EPS (ttm):-0.09
Qtrly Earnings Growth (yoy): N/A
Balance Sheet
Total Cash (mrq):1.06M
Total Cash Per Share (mrq):0.012
Total Debt (mrq):5.33M
Total Debt/Equity (mrq):N/A
Current Ratio (mrq):2.251
Book Value Per Share (mrq):0.682
Cash Flow Statement
Operating Cash Flow (ttm):-5.42M
Levered Free Cash Flow (ttm):-9.25M




% Held by Insiders[SIZE=-1]1[/SIZE]:40.45%
% Held by Institutions[SIZE=-1]1[/SIZE]:53.00%

Short % of Float (as of 09-Apr-09)[SIZE=-1]3[/SIZE]:8.20%


Shares Outstanding[SIZE=-1]5[/SIZE]:90.12M
 
Ultima modifica:
qui va molto meglio :

diagnostica e farmaci il settore


high 52 week ben 5,6$

3 milioni di pezzi scambiati negli ultimi 10 gg

50% di istituzionali dentro


cash flow operativo positivo


o,6$ di capitale proprio su' azione

short accettabile 7,9%
 

Users who are viewing this thread

Back
Alto